| Date | Title | Description |
| 30.06.2026 | Lys Therapeutics Secures Over €25M for Neuro-Therapeutic Advancement | Lys Therapeutics has secured over €25 million in combined funding. This capital propels LYS241, its innovative biotherapeutic, towards clinical trials. LYS241 targets critical neurovascular and neurodegenerative conditions. It aims to rever... |
| 25.06.2026 | Lys Therapeutics Raises €25+ Million To Advance LYS241 Toward Clinical Development | Lys Therapeutics announced that it has raised more than €25 million since its founding in 2021. The financing will support the advancement of the company’s lead candidate, LYS241, toward clinical development in neurology.
Lys Therapeutics i... |
| 23.06.2026 | Lys Therapeutics Raises Over €25M in Funding | Lys Therapeutics, a Lyon and Caen, France-based developer of neurovascular and neurodegenerative disease-modifying biotherapeutics, raised over €25m in combined funding since its inception.
The round includes a $5m grant from The Michael J.... |
| 18.06.2026 | Neuron23 Receives $2.5 Million Grant From The Michael J. Fox Foundation To Expand Phase 2 Parkinson’s Trial | Neuron23, a clinical-stage biotechnology company developing precision medicines for Parkinson’s disease, announced it received a $2.5 million grant from The Michael J. Fox Foundation for Parkinson’s Research to support the expansion of its ... |
| 17.03.2026 | Metabolon Collaborates with The Michael J. Fox Foundation to Advance Multiomic Analyses for Parkinson's Research | Partnership supports expanded biomarker discovery efforts within MJFF's Parkinson's Progression Markers Initiative
MORRISVILLE, N.C., March 17, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions adva... |
| 10.03.2026 | Casma Therapeutics: $7.6 Million MJFF Funding To Advance TRPML1 Agonist CSM-101 For Parkinson’s Disease | Casma Therapeutics announced that it has received approximately $7.6 million in funding from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support the advancement of its lead therapeutic candidate, CSM-101. The funding wi... |
| 19.02.2026 | Verily Launches Self-Serve Access to Pre Platform with New Segmed and RefinedScience Datasets | What You Should Know
The Launch: Alphabet’s Verily is lowering the barrier to entry for biomedical research by launching a free, self-serve “Standard tier” for its Pre precision health platform.
The Tech: Researchers can now instantly acces... |
| 29.01.2026 | Early signs of Parkinson’s can be identified in the blood | Early signs of Parkinson’s can be identified in the blood
Thu, Jan 29, 2026 07:00 CET Report this content
A team led by researchers at Chalmers University of Technology, Sweden, has succeeded in identifying biomarkers for Parkinson’s diseas... |
| 16.11.2025 | Booster Therapeutics: $5 Million Grant Secured From The Michael J. Fox Foundation | Booster Therapeutics has received a $5 million research grant from The Michael J. Fox Foundation for Parkinson’s Research. The award, part of the Foundation’s Therapeutics Pipeline Program, will accelerate the development of a new class of ... |
| 15.10.2025 | Mission Therapeutics Raises $13.3M in Funding | Mission Therapeutics, a Cambridge, UK-based clinical-stage biotech developing first-in-class therapeutics that promote cell and organ health by enhancing mitophagy, raised $13.3m in funding.
The financing was led by current investors Pfizer... |
| 26.09.2025 | Lys Therapeutics Secures $5M MJFF Grant for Parkinson’s Treatment | What You Should Know:
– Lys Therapeutics, a French biotechnology company, has announced a $5M grant award from The Michael J. Fox Foundation for Parkinson’s Research (MJFF).
– The significant funding, part of MJFF’s Therapeutic Pipeline Pro... |
| 11.09.2025 | Octave Bioscience Secures Major Funding for Precision Neurology Advancement | Octave Bioscience secured $51.1 million in fresh capital. This includes a $35.6 million Series C equity round and a $15.5 million debt facility. Funds accelerate MSDA test commercialization. This blood-based diagnostic tool measures Multipl... |
| 11.09.2025 | XingImaging in partnership with SynuSight was awarded a grant from The Michael J. Fox Foundation to support development of the α-synuclein PET tracer 18F-FD4 for Parkinson's disease | NEW HAVEN, Conn., Sept. 11, 2025 /PRNewswire/ -- XingImaging in partnership with SynuSight Biotech has received funding of $3.84M from The Michael J. Fox Foundation to conduct studies on 18F-FD4, a specific α-synuclein (α-syn)-targeted PET ... |
| 10.09.2025 | Octave Bioscience: $35 Million Raised For Advancing Precision Care For Neurological Diseases | Octave Bioscience, a company focused on precision medicine for neurodegenerative conditions, has announced the successful close of a $35.6 million Series C equity financing round. In addition to this funding, the company has secured a $15.5... |
| 05.09.2025 | Octave Bioscience Raises $35M in Series C Financing | Octave Bioscience, a Menlo Park, CA-based commercial stage precision care company, announced the close of its $35.6M Series C equity financing and that it has entered into a $15.5M non-dilutive term loan agreement with Silicon Valley Bank (... |
| 07.08.2025 | American Parkinson Disease Association Appoints Anne Hubbard as First Chief Public Policy Officer to Lead New Advocacy Department | Anne Hubbard
Experienced leader to amplify the voice of the Parkinson's community through strategic advocacy and public policy initiatives
NEW YORK, Aug. 7, 2025 /PRNewswire-PRWeb/ -- The American Parkinson Disease Association (APDA), a lea... |
| 30.04.2025 | Verily Receives $14.7M Grant from Michael J. Fox Foundation to Create Rich Molecular Dataset for Parkinson’s Research | What You Should Know:
– Verily, an Alphabet company focused on health data platforms and AI, today announced it has received a significant $14.7M grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF).
– The funding will s... |
| 31.03.2025 | Endlyz Therapeutics launches and unveils its portfolio of programmes targeting Parkinson’s disease | London, 31 March 2025 – Endlyz Therapeutics officially emerges from stealth, unveiling its therapeutic pipeline of small molecule modulators targeting ATP13A2 and ATP10B to restore lysosomal function in Parkinson’s (PD) and other neurodegen... |
| 25.03.2025 | New Parkinson’s treatment developed at Stanford could help millions | A study published this month predicts that 25 million people worldwide will be living with the disease by 2050. The U.S., where a million people have the disease, reports 90,000 new diagnoses each year.
The emerging aDBS therapy is a quantu... |
| 18.03.2025 | Neurolixis Publishes Positive Phase 2A Trial Results for NLX-112 in Parkinson’s Disease | NLX-112 Shows Groundbreaking Dual Efficacy in Reducing Levodopa-Induced Dyskinesia and Parkinsonian Motor Symptoms
NLX-112's first-in-class mechanism of action, selectively targeting the serotonin system rather than dopamine, offers a novel... |
| 15.03.2025 | Bridging the Gap: AI and Ibogaine in Modern Healthcare | In the ever-evolving landscape of healthcare, two innovative approaches are emerging as potential game-changers: artificial intelligence (AI) in elderly care and Ibogaine therapy for Parkinson's disease. Both represent a shift towards more ... |
| 14.03.2025 | Ibogaine for Parkinson's: A Groundbreaking Treatment at MindScape Retreat in Cozumel, Mexico | Ibogaine for Parkinsons
A Revolutionary Approach to Neurodegeneration
MIAMI, March 14, 2025 /PRNewswire-PRWeb/ -- Parkinson's disease (PD) is a chronic, progressive neurological disorder that affects millions worldwide. It disrupts motor fu... |
| 11.02.2025 | The Dawn of Current AI: A New Era for Socially Responsible Technology | In the heart of Paris, a significant shift in the landscape of artificial intelligence (AI) is unfolding. The Current AI initiative has emerged as a beacon of hope, aiming to steer AI development toward the greater good. With a promise of $... |
| 10.02.2025 | Current AI: финансирование проектов AI, направленных на решение социальных проблем | Current AI — компания, которая позиционируется как инициатива в интересах общества, направленная на стимулирование и управление развитием искусственного интеллекта в социально значимых направлениях, была анонсирована на французском саммите ... |
| 10.01.2025 | The Nat'l Black Church Initiative is Joining with The Michael J Fox Foundation to Raise Awareness of Parkinson's Disease | Rev Anthony Evans, President of the National Black Church Initiative
Logo of the The Michael J. Fox Foundation for Parkinson’s Research (MJFF)
We are both honored and proud of The Michael J. Fox Foundation for their brilliant research and a... |
| 05.01.2025 | A Tale of Two Legacies: Biden's Honors and Trump's Trials | In the swirling winds of American politics, two narratives unfold. One is a celebration of achievement; the other, a courtroom drama. On one side, President Joe Biden prepares to bestow the Presidential Medal of Freedom to a diverse group o... |
| 04.01.2025 | Bono, Messi, Soros to get Presidential Medal of Freedom from Biden | WASHINGTON: Joe Biden on Saturday (Jan 4) will award the Presidential Medal of Freedom to 19 honorees, bestowing the highest civilian honour in the United States to entertainers, sports stars, politicians and diplomats.
Among those to recei... |
| 04.01.2025 | Bono, Messi, Soros awarded Presidential Medal of Freedom by Biden | WASHINGTON: Joe Biden on Saturday awarded the Presidential Medal of Freedom to 19 honorees, bestowing the highest civilian honour in the United States on entertainers, sports stars, activists and diplomats including Jane Goodall and Hillary... |
| 25.11.2024 | HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Announce Successful Completion of a First-in-Human Study for Potential Disease-Modifying Therapy for Parkinson's Disease | HL192 (ATH-399A) was well tolerated with no major safety issues in any of the 76 participants.
No serious treatment related adverse events were reported and such findings were proportional between placebo and dosed groups.
PK results suppor... |
| 19.11.2024 | Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson's Research Through Development of Next Generation Biomarker Assays | FREMONT, Calif., Nov. 19, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce a strategic collaboration with The Michael J. Fox Foundation for ... |
| 26.10.2024 | Starburst Ignites Data Streaming Revolution with New Ingestion Capabilities | In the world of data analytics, speed is king. Businesses crave real-time insights. Starburst, a leader in data platforms, has unveiled a game-changing solution. Their latest offering allows for streaming ingestion from Apache Kafka to Apac... |
| 25.10.2024 | 2024 MEDIA ACCESS AWARDS Announces Host, Honorees, Presenters and Performers | Media Access Awards 2024
Evening Will Honor Michael J. Fox, Jillian Mercado, Shoshannah Stern, Marion Dayre Joshua Feldman, Maribeth Fox, Danny Kurtzman and Eric Graise; Presenters Include Selma Blair, Jimmy Kimmel, Marlee Matlin and More; ... |
| 18.10.2024 | Allyx Therapeutics: $3.3 Million Grant Awarded From NIH | Allyx Therapeutics announced that it has been awarded a $3.3 million grant from the National Institutes of Health as part of its Small Business Innovation Research Commercial Readiness Pilot program. This funding round will support further ... |
| 13.08.2024 | Invest in Others Charitable Foundation Honors Sanjiv Mirchandani with Inaugural Executive Tribute, Honoring Outstanding Leadership | In Recognition of Fidelity Institutional Veteran's Efforts to Raise Funds & Awareness for the Michael J. Fox Foundation, Special Campaign Aims to Raise $500,000 to Benefit This Charity and IiO
BOSTON, Aug. 13, 2024 /PRNewswire/ -- The I... |
| 02.08.2024 | Rowers Complete Record-breaking 2,800-mile Open Ocean Row to Benefit Michael J. Fox Foundation, Increase Fundraising Goal to $41 Million | "Team Human Powered Potential" blows through original $28 million fundraising goal
With the original milestone completed, and thanks to the continued generosity of an anonymous donor, an increased $41M goal has been set in honor o... |
| 12.06.2024 | Latest Updates of Viva Biotech's Portfolio Companies | HONG KONG, June 12, 2024 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies... |
| 23.05.2024 | The Michael J. Fox Foundation Applauds Passage of National Plan to End Parkinson's Act in Congress | The National Plan establishes a federal advisory council dedicated to finding a cure for Parkinson's disease.
NEW YORK, May 23, 2024 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) today celebrates the passage ... |
| 19.05.2024 | Courteney Cox: Designing woman | Dressed in black on the white sands of Miami Beach, Courteney Cox struck a pose during a recent photo shoot. The camera was on her, but she's the one hyper-focused. "I always say, 'I suffer from acute awareness,'" she said. "... |
| 11.03.2024 | AbbVie’s Produodopa® (foslevodopa-foscarbidopa) Accepted by Scottish Medicines Consortium as Treatment Option for Advanced Levodopa-Responsive Parkinson’s Disease | AbbVie’s Produodopa® (foslevodopa-foscarbidopa) Accepted by Scottish Medicines Consortium as Treatment Option for Advanced Levodopa-Responsive Parkinson’s Disease
Mon, Mar 11, 2024 12:12 CET Report this content
For Medical and Trade media.
... |
| 11.03.2024 | Nitrase Therapeutics Unveils Pioneering Antibody Candidate for Parkinson’s Disease Based on Nitration Discovery in Oral Presentation at the Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Conferen... | -Nitrase’s first-in-class antibody found to significantly delay progression of Parkinson’s disease in preclinical models by blocking the propagation of pathogenic nitrated synuclein
-Advancing development candidate NDC-0524 into IND-enablin... |
| 20.02.2024 | Study Finds Link Between Agent Orange Exposure and Brain Damage | Bárbara Pinho , Tech Times 20 February 2024, 10:02 am
(Photo : Photo by Paula Bronstein /Getty Images) Handicapped orphans sit in their chairs waiting for lunch at the Ba Vi orphanage March 15, in Ba Vi, Vietnam.
A new study of rat brain ce... |
| 26.12.2023 | Soturi Health – Newel Health Launches Groundbreaking Parkinson’s Disease Study | Initiates Recruitment for “NWL-SOT-CS-001” Clinical Study with Generous Funding from The Michael J. Fox Foundation
Shortly after presenting Soturi at Frontiers Health 2023, Newel Health, a leading digital therapeutic solution provider, is ... |
| 24.05.2023 | H1 and The Michael J. Fox Foundation team up to fuel Parkinson's research | MJFF will be able to use H1's platform to run more diverse clinical trials
Parkinson's disease has been notoriously been difficult to cure. Nearly one million people in the United States alone, and over six million people worldwide, have it... |
| 20.05.2023 | 15 photos show Michael J. Fox's career through the years, from 'Back to the Future' to a congressional hearing with Muhammad Ali | Entertainment 15 photos show Michael J. Fox's career through the years, from 'Back to the Future' to a congressional hearing with Muhammad Ali
Lauren Edmonds
2023-05-20T19:56:54Z
Share icon An curved arrow pointing right.
Share
Facebook Ico... |
| 12.05.2023 | Michael J. Fox says he's suffered numerous injuries as a result of his Parkinson's | Michael J. Fox has suffered from a number of injuries as a result of his Parkinson's disease, which he was diagnosed with in 1991 at age 29, the actor revealed in an interview with Variety this week.
The 61-year-old "Back to the Future... |
| 12.05.2023 | Whelen Engineering and Team Fox Racing for a Cure Announce Mazda MX-5 Cup Car Giveaway | Mazda MX-5 Cup Car valued at $100,000
Visit RacingForACure.Giving to make a donation and be entered to win.
Front view of Mazda MX-5 Cup Car
Cup Car to Be Unveiled at Laguna Seca Raceway in Monterey, California on May 12, 2023
I am especial... |
| 30.04.2023 | Michael J. Fox on Parkinson's and how he finds "optimism is sustainable" | Michael J. Fox remembered the first time he came to New York City, to meet with Jane Pauley on "The Today Show." "Me and my friend who came with me to New York wandered down Fifth, and we were at breakfast. And it was $20. I ... |
| 28.04.2023 | Preview: Michael J. Fox on Parkinson's, and optimism | Actor Michael J. Fox was diagnosed with early-onset Parkinson's disease in 1991 when he was just 29. In an interview with "CBS Sunday Morning" anchor Jane Pauley, Fox, now 61, says dealing with the incurable disease is getting mor... |
| 20.03.2023 | Neurolixis Announces Positive Ph2A Proof-of-Concept on NLX-112 in Levodopa-Induced Dyskinesia in Parkinson’s Disease | A New Approach Using a First-in-Class Highly Selective and Efficacious Serotonin 5-HT1A Receptor Biased Agonist
We are excited about the positive results of this proof-of-concept study; the findings indicate that NLX-112 can be safely admin... |
| 31.10.2022 | After year of multiple broken bones, Michael J. Fox says he has one mission: "Don't fall down" | Michael J. Fox has revealed new details about a tumultuous year of health problems as he continues to battle Parkinson's disease. In a cover story interview for People Magazine, Fox shared that the past year came with a personal loss and a ... |
| 01.06.2022 | Alzprotect Awarded a Grant from The Michael J. Fox Foundation to Advance Small Molecule Parkinson’s Disease Program | Logo Alzprotect
Phil Verwaerde
MJFF
Alzprotect, a French biopharmaceutical company has been awarded a USD $338,000 grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF)
We are very proud of the recognition of our prelimin... |
| 05.05.2022 | Asceneuron obtains grant to advance treatment for Parkinson’s Disease | |
| 05.04.2022 | Nitrase Therapeutics Receives New Grant from The Michael J. Fox Foundation for Parkinson’s Research | BRISBANE, Calif., April 05, 2022 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its unique NITROME platform to unlock the therapeutic potential of nitrases, a new class of enzymes discovered by the com... |
| 28.10.2021 | Gain Therapeutics to Present at Upcoming Medical Conferences | - The Michael J. Fox Foundation’s Parkinson’s Disease Therapeutics Webinars -
- Society of Neuroscience 50th Anniversary Meeting –
BETHESDA, Md., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Comp... |
| 28.10.2021 | 21 celebrities you didn’t realize were immigrants | Natalie Portman was born in Israel. Frazer Harrison/Getty Images
National Immigrants Day falls on October 28 every year.
Some of Hollywood’s biggest stars are from countries including India, Canada, Ireland, and Colombia.
Salma Hayek overst... |
| 12.10.2021 | Joining forces with new and existing partners | |
| 08.09.2021 | Press Release : Gain Therapeutics, Inc. Announces -2- | Medicine is ranked #9 among the 92 public medical schools in the U.S., and in the top 15 percent (#27) of all 192 public and private U.S. medical schools. The School of Medicine works locally, nationally, and globally, with research and tre... |
| 08.09.2021 | Gain Therapeutics : Announces Positive Topline Data in Patient-derived iPSC Study Evaluating STAR Compounds as a Treatment for Gaucher and Parkinson's Disease | GT-02287and GT-02329 compounds display positive effects on GCase activity and related parameters
---
Study results demonstrate an increase in GCase protein levels with transport to the lysosomes and decrease of glucosylceramide and α-synucl... |
| 21.07.2021 | 5 major health benefits of garlic, from boosting your immune system to lowering cholesterol | For maximum health benefits, buy whole garlic versus the pre-minced version in jars. Westend61/Getty inages
Garlic benefits include improving heart health and reducing the risk of certain cancers.
One garlic clove also contains important vi... |
| 20.04.2021 | The Michael J. Fox Foundation for Parkinson's Research Adds Melanie Bolch Isbill, Alex Krys and Jack Quinn to Its Board of Directors | NEW YORK, April 20, 2021 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced that during its Board meeting on March 11, 2021, three new members were appointed to the Board of Directors — Melanie Bolch Isb... |
| 09.02.2021 | Alterity Therapeutics announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson's disease clinical trials | |
| 05.12.2019 | Apple Reveals a Possible Future Health app for Apple Watch and an MR Headset to Assist those with Parkinson's Disease
Categories
Search | The U.S. Patent Office published a patent application from Apple relating to a possible new Apple Watch health app relating to managing chronic disease and helping patients better engage with clinicians. More specifically, the Apple Watch a... |
| 02.10.2019 | ND BioSciences receives The Michael J. Fox Foundation grant | |
| 17.07.2019 | Elon Musk Announces Plan to 'Merge' Human Brains With AI | Elon Musk announced late Tuesday night that the final goal of Neuralink, his brain-machine interface startup, is to allow humans to “achieve a symbiosis with artificial intelligence,” and that by “merging with AI,” humans will be able to ke... |
| 25.06.2019 | PhoreMost and C4X Discovery announce neurodegeneration focused drug discovery collaboration | PhoreMost and C4X Discovery announce neurodegeneration focused drug discovery collaboration
25-06-2019
PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and C4X Discovery Holdings... |
| 25.03.2019 | Inflazome receives funding from The Michael J. Fox Foundation for Parkinson’s research | Inflazome receives funding from The Michael J. Fox Foundation for Parkinson’s research
25-03-2019
Inflazome, the pioneering biotech company developing several small molecule drugs that inhibit harmful inflammation, today announces it has be... |
| 25.03.2019 | Inflazome receives funding from The Michael J. Fox Foundation for Parkinson’s research | Inflazome, the pioneering biotech company developing several small molecule drugs that inhibit harmful inflammation, today announces it has been awarded funding in excess of US$1 million by The Michael J Fox Foundation for Parkinson’s Resea... |
| 13.03.2019 | Two foundations join forces to fund Gain Therapeutics’ approach for Parkinson’s | |
| 31.01.2019 | Multi-target drugs should be in the pharma pipeline along with precision drugs | Precision medicine — providing the right treatment, for the right patient, at the right time — is saving lives. The use of therapies that home in on single targets is helping beat tough-to-treat diseases that were often deadly in the past.
... |
| 11.01.2019 | Virtual repurposing can speed the discovery of new uses for existing drugs | The process for discovering drugs tends to be based on the same kind of pigeonholing that doctors use to treat disease: Parkinson’s is one disease, Crohn’s is something completely separate. A new approach, sometimes called virtual repurposi... |
| 26.10.2018 | Michael J. Fox Foundation taps Philly startup for Parkinson’s research | Think of the Michael J. Fox Foundation, founded by the Back to the Future star in 2000 after he revealed his Parkinson’s diagnosis, as the center of the ailment’s universe.
To date, the New York nonprofit has raised around $800 million for ... |
| 24.09.2018 | MouSensor Closes a $3.3M Seed Round | MouSensor, Inc., a biotechnology company that develops a novel and potentially transformative platform to digitize the sense of smell, announced today that it has raised $3.3M in its seed round. The seed round was co-led by imec.xpand and A... |
| 15.05.2018 | Wearables build momentum for Parkinson’s disease research | The types of data collected will include movement and different types of physiologic and environmental information nearly all day, every day, according to a description of the study. Verily and PPMI will make raw and curated data available ... |
| 23.07.2017 | What AI-enhanced health care could look like in 5 years | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
This summer, KPCB partner Mary Meeker’s 2017 Inte... |
| 23.07.2017 | What AI-enhanced health care could look like in 5 years | This summer, KPCB partner Mary Meeker’s 2017 Internet Trends report singled out healthcare as a sector ripe with opportunity. The report proposed that the healthcare market, driven by a number of converging technologies, is approaching a “d... |
| 20.10.2016 | The Nike Mag sneaker raffle raised $6.75 million for Parkinson’s research | It was pretty easy to lose sight of the bottom line in all of the hype and neon lights and childhood wish fulfillment. But at the end of the day, the extremely limited number of self-lacing Mag sneakers Nike was raffling off were supporting... |
| 06.10.2016 | Trying on Nike’s limited edition, self-lacing ‘Back to the Future’ shoes | Nike announced earlier this week that it will be releasing a new edition of the Nike Mags, its self-lacing shoes inspired by Back to the Future — but only 89 pairs, which will be raffled off (tickets cost $10), with proceeds benefiting the ... |
| 04.10.2016 | Nike will raffle off its super-limited-edition ‘Back to the Future’ kicks for a good cause | When Nike said it was making the 2016 version of its Back to the Future-inspired shoes limited edition, the company wasn’t messing around. Only 89 pairs of the self-lacing shoes will be released to the public (likely not a coincidental nod ... |
| 04.10.2016 | Nike is giving away its Back to the Future self-lacing sneakers | The self-lacing sneakers that Michael J. Fox wore in Back to the Future II are now a reality, and Nike has set up a way to win a pair through the crowdfunding platform RallyUp as part of a promotion for the Michael J. Fox Foundation.
The se... |
| 30.08.2016 | As Parkinson’s patients wait, Fox Foundation and scientist feud over drug trial | A crucial clinical trial of the most promising new treatment for Parkinson’s disease in decades might be delayed because of a feud between a key scientist and the influential Michael J. Fox Foundation.
The prominent foundation — the richest... |
| 30.06.2016 | Drive to get more patients experimental stem cell treatments stirs concern | On both coasts, campaigns are building to get desperate patients faster access to stem cell treatments — in some cases, before they are proven to work. And that is making some scientists nervous.
In Washington, a US senator recently introdu... |
| 04.06.2016 | Muhammad Ali and Parkinson’s disease: Was boxing to blame? | Muhammad Ali was still boxing professionally when observers first noticed signs of neurological decline, and many have been quick to link his profession to his diagnosis, years later, of Parkinson’s disease.
In the decades that followed, an... |
| 16.09.2015 | Aleva Neurotherapeutics awarded Grant from The Michael J. Fox Foundation | |
| 29.04.2015 | Brain prosthetics? Neuromodulation? The ‘disruptive dozen’ techs that’ll accelerate neuropsychiatric care | Alzheimer’s-in-a-dish: It’s now possible to replicate human brain cells on a petri dish, helping researchers sidestep the lobotomy to learn a bit more about Alzheimer’s intricate biology.
Experimental drugs to reduce beta amyloid and lessen... |
| 20.04.2015 | HomeLabs looks to brain games to raise awareness for Parkinson’s Disease | One studio hopes to use brain games to raise awareness for a brain disease.
New game developer HomeLabs aims to use brain-training games for mobile devices and related social efforts to raise awareness for Parkinson’s Disease, a progressive... |
| 20.11.2014 | Healthcare’s Big Data Opportunity | David Richards Contributor
More posts by this contributor
Examining Tech Solutions To Natural Disasters
Building A Data-Driven White House
Editor’s note: David Richards is the co-founder and CEO of WANdisco.
The hospitals where my grandchil... |
| 04.11.2014 | Gardedam Therapeutics could name its drug after you! (If you donate enough to its crowdfunding effort) | Gardedam targets the DJ-1 protein – whose loss and reduction in function has been linked to Parkinson’s, Alzheimer’s, stroke, COPD and type II diabetes. Stabilizing DJ-1 from protein misfolding could help protect from oxidative stress – a h... |
| 22.08.2014 | Fat-based Parkinson’s drug headed to clinical trial with $6.5M in angel money | Researchers thought as far as two decades back they could treat oxidative stress by giving patients antioxidants and even good fats, but have since found that such a heavy-handed approach to neurodegenerative disease just doesn’t quite work... |
| 14.04.2014 | Domain Therapeutics Receives $230K Second Grant from Michael J. Fox Foundation | Domain Therapeutics, a Strasbourg, France- and Montreal, Canada-based biopharmaceutical company dedicated to altering course of Parkinson’s disease, received a second grant of $230k from The Michael J. Fox Foundation (MJFF).
The grant will ... |
| 26.03.2013 | Biotech startup raises $1M for lung cancer treatment using component of tumeric | It is believed to interact with cell survival, division, and death signaling pathways, interfering with or eliminating cancer and neuropathic disorders, according to SignPath’s website.
Dr.Lawrence Helson, the CEO of the Quakertown, Pennsyl... |
| 14.05.2012 | Morning Read: CMS adds advanced practice nurses, pharmacists to ‘medical staff’ | Sergey Brin and Anne Wojcicki are continuing to support research into Parkinson’s disease and are seeing some progress. They have donated $124.9 million to the Michael J. Fox Foundation for Parkinson’s Research and the foundation in turn ha... |
| 08.05.2012 | Envoy Therapeutics Receives $1.2M Grant from The Michael J. Fox Foundation | Envoy Therapeutics, Inc., a Jupiter, Florida–based drug discovery company, has been awarded a $1.2m second grant from The Michael J. Fox Foundation (MJFF).
The company intends to use the funding for the continued development of compounds th... |
| 17.04.2012 | Researchers map out how Parkinson’s disease progresses in brain | Although the accumulation of misfolded proteins is fundamental in the development of neurodegenerative diseases, the factors that trigger aggregation of a-syn proteins are poorly understood, a statement from Penn about the study said.
When ... |
| 08.12.2011 | 4 tips for life sciences companies seeking foundation funding | “Our job is to put the ball in the air, throw the long ball,” he said.
Angel investors and venture capitalists are not the only path for companies looking to traverse the so-called valley of death. Life sciences companies have a funding alt... |
| 28.11.2011 | Sapiens Steering Brain Stimulation Raises €10M in Funding | Sapiens Steering Brain Stimulation, an Eindhoven, The Netherlands-based emerging medical device company, has secured a total of €10m additional funding.
The company intends to use the capital, which supplements an initial €13m Series A fund... |
| 14.11.2011 | 2011 NIKE MAG Auction | $4.7 Million Raised for The Michael J. Fox Foundation for Parkinson’s Research
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) today announced that Nike’s total funds raised for the Foundation, generated by the 10-day eBay auc... |
| 15.11.2010 | Nonprofit takes risk out of device development for Medtronic | For companies like Medtronic Inc. (NYSE:MDT), developing breakthrough technologies to treat untreatable diseases can be expensive and have little promise of financial returns.
The risk is high enough for — even companies as well-resourced a... |
| 12.11.2010 | Medtronic’s research partnership: a roadmap to the future? | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| - | 4 tips for life sciences companies seeking foundation funding | Max Wallace, CEO of Accelerate Brain Cancer Cure, uses a football analogy when explaining his foundation’s approach to funding life sciences research.
Large companies aren’t getting into the game, which they see as too risky. But the stakes... |
| - | Fat-based Parkinson’s drug headed to clinical trial with $6.5M in angel money | There’s a generalized consensus that “good” fats – like Omega-3 fatty acids – could help improve mental acuity, even combat neurodegenerative disease. Bay Area startup Retrotope is riffing off this idea, engineering what could be a super-go... |
